A PYMNTS Company

US: FTC approves conditions on UnitedHealth’s buy of DaVita

By  |  August 22, 2019

The Federal Trade Commission has approved a final order settling charges that UnitedHealth Group’s proposed US$4.3 billion acquisition of DaVita Medical Group from DaVita will likely harm competition in healthcare markets in Clark and Nye Counties, Nevada.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The order requires United, no later than 40 days after the acquisition is final, to divest DaVita Medical Group’s healthcare provider organization in the Las Vegas Area (known as HealthCare Partners of Nevada) to Intermountain Healthcare, a Utah-based healthcare provider and insurer.

    According to the complaint, which was first announced in June 2019, without a remedy in the Las Vegas Area, the proposed acquisition would likely have reduced competition in the markets for managed care provider organization services sold to Medicare Advantage insurers, and Medicare Advantage plans sold to individual Medicare Advantage members.

    Full Content: FTC

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.